Objective Mild cognitive impairment and dementia are common non-motor features of
Parkinson's disease (PD). The aim of this study was to characterise grey matter changes …

There is growing interest in identifying Parkinson's disease (PD) patients with mild cognitive
impairment (PD‐MCI), but widely disparate criteria have been used. We assessed 143 PD …

There is a need for objective imaging markers of Parkinson’s disease status and progression.
Positron emission tomography and single photon emission computed tomography studies …

Objectives: To characterize different stages of Parkinson disease (PD)-related cognitive
decline using diffusion tensor imaging (DTI) and investigate potential relationships between …

Emerging evidence suggests that Alzheimer's disease (AD) and Parkinson's disease dementia
(PDD) share neurodegenerative mechanisms. We sought to directly compare cerebral …

The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for
mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of …

The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded
beta-amyloid, contributes to cognitive decline and dementia in Parkinson's disease (PD) is …

Studies of saccades in Parkinson's disease (PD) have seldom examined the influence of
cognitive status, ranging from normal cognition, through mild cognitive impairment, to dementia. …

Background There is limited evidence on caregiver outcomes associated with mild cognitive
impairment in patients with Parkinson’s disease (PD-MCI) and the coping strategies used …

Background & Objectives Cross-sectional magnetic resonance imaging (MRI) suggests that
Parkinson’s disease (PD) is associated with changes in cerebral tissue volume, diffusion …